Literature DB >> 15047015

Estrogen and progesterone dose-dependently reduce disruptive effects of restraint on lordosis behavior.

Stacy White1, Lynda Uphouse.   

Abstract

Ovariectomized rats were hormonally primed with various doses of estradiol benzoate (EB; 0.5-10 microg) in combination with various doses of progesterone (2.5-500 microg) to induce sexual receptivity. Females were then subjected to 5 min restraint and the effect on lordosis behavior was monitored for the next 30 min. Such mild stress has been previously shown to transiently reduce lordosis behavior of ovariectomized females hormonally primed only with 10 microg EB. In the current study, doses of progesterone of 25 microg or more in combination with 10 microg EB reduced the effects of restraint. Also priming doses of EB from 4.0 to 10 microg in combination with 250 microg progesterone prevented the lordosis-inhibiting effects of restraint. These findings reinforce prior observations of the dose-dependency of both estrogen and progesterone in the facilitation of lordosis behavior and introduce the female's lordosis response to mild restraint as a potentially useful index of the female's response to stress.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15047015     DOI: 10.1016/j.yhbeh.2003.10.001

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  32 in total

1.  Mechanisms responsible for progesterone's protection against lordosis-inhibiting effects of restraint I. Role of progesterone receptors.

Authors:  James Hassell; Chandra Suma Johnson Miryala; Cindy Hiegel; Lynda Uphouse
Journal:  Horm Behav       Date:  2011-05-20       Impact factor: 3.587

2.  Use of an operant paradigm for the study of antidepressant-induced sexual dysfunction.

Authors:  Lynda Uphouse; Jonathan Pinkston; Duane Baade; Christian Solano; Bless Onaiwu
Journal:  Behav Pharmacol       Date:  2015-10       Impact factor: 2.293

3.  Fluoxetine prevents 8-OH-DPAT-induced hyperphagia in Fischer inbred rats.

Authors:  Chandra Suma Johnson Miryala; Navin Maswood; Lynda Uphouse
Journal:  Pharmacol Biochem Behav       Date:  2011-01-28       Impact factor: 3.533

4.  Comparison of female Fischer and Sprague-Dawley rats in the response to ketanserin.

Authors:  Chandra Suma Johnson Miryala; Cindy Hiegel; Lynda Uphouse
Journal:  Pharmacol Biochem Behav       Date:  2013-11-04       Impact factor: 3.533

5.  Prior hormonal treatment, but not sexual experience, reduces the negative effects of restraint on female sexual behavior.

Authors:  Lynda Uphouse; Cindy Hiegel; Sarah Adams; Vanessa Murillo; Monique Martinez
Journal:  Behav Brain Res       Date:  2013-10-27       Impact factor: 3.332

6.  A comparison of the effects of male pheromone priming and optogenetic inhibition of accessory olfactory bulb forebrain inputs on the sexual behavior of estrous female mice.

Authors:  Elizabeth A McCarthy; Tenzin Kunkhyen; Wayne J Korzan; Ajay Naik; Arman Maqsudlu; James A Cherry; Michael J Baum
Journal:  Horm Behav       Date:  2017-01-05       Impact factor: 3.587

7.  Progesterone reduces the effect of the serotonin 1B/1D receptor antagonist, GR 127935, on lordosis behavior.

Authors:  Lynda Uphouse; Cindy Hiegel; Jutatip Guptarak; Navin Maswood
Journal:  Horm Behav       Date:  2008-10-08       Impact factor: 3.587

8.  Allopregnanolone's attenuation of the lordosis-inhibiting effects of restraint is blocked by the antiprogestin, CDB-4124.

Authors:  Lynda Uphouse; Cindy Hiegel
Journal:  Pharmacol Biochem Behav       Date:  2014-03-18       Impact factor: 3.533

9.  An antiprogestin, CDB4124, blocks progesterone's attenuation of the negative effects of a mild stress on sexual behavior.

Authors:  Lynda Uphouse; Cindy Hiegel
Journal:  Behav Brain Res       Date:  2012-11-12       Impact factor: 3.332

10.  Female gonadal hormones, mild restraint, and male preference.

Authors:  L Uphouse; C Hiegel; J Sarkar; J Hurlburt; C Templeton; J Guptarak; N Maswood
Journal:  Pharmacol Biochem Behav       Date:  2008-10       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.